Transaction advisory firm heads to the massive smoke as a part of its enlargement plans
PharmaVentures has introduced that it’s transferring its operational headquarters from Oxford to London, as a part of a continued strategic enlargement. The corporate will retain remaining operational and administrative capabilities at its newly registered workplace in Oxford.
PharmaVentures is a premier transaction advisory agency and a number one worldwide firm in partnering, merger and aquisition offers and strategic alliances. For the final 30 years, the corporate has acted as an advisor on over 900 deal-related tasks within the realm of licensing, mergers, acquisitions, divestments and three way partnership actions for firms worldwide.
The brand new London headquarters is located near Paddington Station, serving each Oxford and London’s Heathrow Airport, which makes it handy for its world purchasers travelling to London.
Dr Fintan Walton, CEO and founding father of PharmaVentures, stated: “As a number one world transaction advisory agency, it is smart that PharmaVentures strikes its practical operations to one of many world’s main monetary cities. We needed a location that displays PharmaVentures’ forward-thinking tradition and enterprise. So, in the long run London was the plain selection.”
The agency has a deep financial institution of specialist expertise, deal analytics and a longtime community of contacts amongst innovators and enormous pharma, which permits it to successfully help companies in all points of deal-making and strategic planning.
PharmaVentures currentlyemploys over 20 professionals and has associates positioned in Europe in addition to the Asia-Pacific area.